blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0391898

EP0391898 - FUSIDIC ACID USEFUL IN THE TREATMENT OF AIDS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.09.1992
Database last updated on 14.11.2024
Most recent event   Tooltip01.09.1992Application deemed to be withdrawnpublished on 21.10.1992 [1992/43]
Applicant(s)For all designated states
FABER, Johan Viggo
Frederiksborggade 43
DK-1360 Copenhagen K / DK
[1990/47]
Former [1990/42]For all designated states
LEO PHARMACEUTICAL PRODUCTS B.V.
Pampuslaan 186
NL-1382 JS Weesp / NL
Inventor(s)01 / FABER, Johan, Viggo
Frederiksborggade 43
DK-1360 Copenhagen K / DK
02 / GODTFREDSEN, Wagn, Ole
Noerrevaenget 34
DK-3500 Vaerloese / DK
[1990/42]
Representative(s)Kjerrumgaard, Bent
Budde Schou A/S
Hausergade 3
1128 Copenhagen K / DK
[N/P]
Former [1990/42]Kjerrumgaard, Bent
c/o Th. Ostenfeld Patentbureau A/S Bredgade 41 P.O. Box 1183
DK-1011 Copenhagen K / DK
Application number, filing date88905837.621.07.1988
[1990/42]
WO1988EP00660
Priority number, dateEP1987011062122.07.1987         Original published format: EP 87110621
EP1988010012807.01.1988         Original published format: EP 88100128
[1990/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO8900424
Date:26.01.1989
Language:EN
[1989/03]
Type: A1 Application with search report 
No.:EP0391898
Date:17.10.1990
Language:EN
The application published by WIPO in one of the EPO official languages on 26.01.1989 takes the place of the publication of the European patent application.
[1990/42]
Search report(s)International search report - published on:EP26.01.1989
ClassificationIPC:A61K31/71, A61K31/56, A61K31/575
[1990/42]
CPC:
A61K31/56 (EP); A61K31/70 (EP); A61P31/12 (EP);
A61P31/18 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1990/42]
TitleGerman:FUSIDINSÄURE VERWENDBAR ZUR BEHANDLUNG VON AIDS[1990/42]
English:FUSIDIC ACID USEFUL IN THE TREATMENT OF AIDS[1990/42]
French:ACIDE FUSIDIQUE UTILE DANS LE TRAITEMENT DU SIDA[1990/42]
File destroyed:12.06.1999
Entry into regional phase22.01.1990National basic fee paid 
22.01.1990Designation fee(s) paid 
22.01.1990Examination fee paid 
Examination procedure17.02.1989Request for preliminary examination filed
International Preliminary Examining Authority: DE
22.01.1990Examination requested  [1990/42]
31.05.1991Despatch of a communication from the examining division (Time limit: M04)
16.09.1991Reply to a communication from the examining division
17.10.1991Despatch of communication of intention to grant (Approval: Yes)
14.01.1992Communication of intention to grant the patent
25.04.1992Application deemed to be withdrawn, date of legal effect  [1992/43]
25.05.1992Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [1992/43]
Fees paidRenewal fee
09.07.1990Renewal fee patent year 03
08.07.1991Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0217580  (WELLCOME FOUND [GB])
 [XP]  - The Lancet, vol. 2/8563, 10 Octobre 1987, V. Faber et.: 'Inhibition of HIV replication in vitro by fusidic acid', pages 827 - 828
 [XP]  - Science, vol. 238, no. 4825, 16 octobre 1987, D.M. Barnes: 'On the shelf' AIDS drug in clinical trial', page 276
 [Y]  - Quarterly Journal of Medicine, New Series 55, no. 216, 14 April 1985, A.M. Geddes et al.: 'Infection in immunocompromised patients', pages 5 - 14, see summary; pages 7 - 9, line 9; page 10, lines 10 - 19
 [Y]  - Chemical Abstracts, vol. 74, no.13, 29th March 1971, Columbus, Ohio (US), T. Goncharskaya et al.: 'Antiviral properties of fusidin', see abtsract no. 73192b & Antibiotiki (Moscow), 1971, 16(1), 57 - 60
 [Y]  - Chemical Abstracts, vol. 77, no. 10, 4th September 1972, Columbus, Ohio (US), S.S. Gerasimova et al.: 'Effect of Fucidin on the reproduction of Venezuelan equine encephalomyelitis virus in tissue culture', see page 92, abstract no. 70720y & Antibiotiki (Moscow), 1972, 17(5), 457 - 461
 [Y]  - Chemical Abstracts, vol. 80.no. 7, 18th February 1974, Columbus,Ohio (US), T. Ya. Goncharskaya et al.: 'Effect of fusidin on smallpox vaccine virus', sse abstract no. 34077x & Antibiotiki (Moscow), 1973, 18 (8), 710 - 713
 [Y]  - Antiviral Research, vol. 4, 1984, 1984 Elsevier Science Publishers (NL), B. Alarcon et al.: 'Screening for new compounds with antiherpes activity', pages 231 - 243, see abstract; page 238, table 2
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.